| P2093 | author name string | Jim Philip | |
| P2860 | cites work | A randomized trial of lower leg and height growth in children with asthma treated with inhaled budesonide from a new dry powder inhaler | Q42615410 |
| | Combination therapy salmeterol/fluticasone versus doubling dose of fluticasone in children with asthma | Q42973500 |
| | Efficacy and safety of three ciclesonide doses vs placebo in children with asthma: the RAINBOW study | Q42974516 |
| | Effects of beclomethasone and factors related to asthma on the growth of prepubertal children | Q43147441 |
| | Inhaled beclomethasone dipropionate improves acoustic measures of voice in patients with asthma | Q43822443 |
| | Growth, systemic safety, and efficacy during 1 year of asthma treatment with different beclomethasone dipropionate formulations: an open-label, randomized comparison of extrafine and conventional aerosols in children | Q44013357 |
| | Biochemical markers of bone metabolism in relation to adrenocortical and growth suppression during the initiation phase of inhaled steroid therapy. | Q44083774 |
| | Lung deposition of hydrofluoroalkane-134a beclomethasone is greater than that of chlorofluorocarbon fluticasone and chlorofluorocarbon beclomethasone : a cross-over study in healthy volunteers | Q44097329 |
| | Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial | Q44388200 |
| | Population pharmacokinetics and pharmacodynamics of ciclesonide. | Q44424374 |
| | Long-term safety of fluticasone propionate and nedocromil sodium on bone in children with asthma | Q44460277 |
| | Does vitamin D administered to children with asthma treated with inhaled glucocorticoids affect short‐term growth or bone turnover? | Q44603732 |
| | Effects of inhaled fluticasone propionate in children less than 2 years old with recurrent wheezing | Q44733659 |
| | Pharmacokinetics of [14C]ciclesonide after oral and intravenous administration to healthy subjects | Q44893665 |
| | Preemptive use of high-dose fluticasone for virus-induced wheezing in young children | Q45387136 |
| | Linear growth and bone maturation are unaffected by 1 year of therapy with inhaled flunisolide hydrofluoroalkane in prepubescent children with mild persistent asthma: a randomized, double-blind, placebo-controlled trial | Q46149181 |
| | Short-term lower-leg growth rate and urine cortisol excretion in children treated with ciclesonide | Q46469353 |
| | The effects of long term use of inhaled corticosteroids on linear growth, adrenal function and bone mineral density in children | Q46620192 |
| | Montelukast, compared with fluticasone, for control of asthma among 6- to 14-year-old patients with mild asthma: the MOSAIC study | Q46630095 |
| | Effects of inhaled corticosteroids on growth in asthmatic children: a comparison of fluticasone propionate with budesonide. | Q46666562 |
| | High lung deposition of 99mTc-labeled ciclesonide administered via HFA-MDI to patients with asthma | Q46794413 |
| | Assessment of the long-term safety of inhaled ciclesonide on growth in children with asthma | Q46856994 |
| | Effect of long-term treatment with inhaled budesonide on adult height in children with asthma | Q47227706 |
| | Effects of inhaled mometasone furoate on growth velocity and adrenal function: a placebo-controlled trial in children 4-9 years old with mild persistent asthma | Q48943114 |
| | Ciclesonide versus other inhaled corticosteroids for chronic asthma in children | Q24200736 |
| | Beclomethasone dipropionate: absolute bioavailability, pharmacokinetics and metabolism following intravenous, oral, intranasal and inhaled administration in man | Q28367487 |
| | Safety of inhaled and intranasal corticosteroids: lessons for the new millennium | Q33983915 |
| | Efficacy and safety overview of a new inhaled corticosteroid, QVAR (hydrofluoroalkane-beclomethasone extrafine inhalation aerosol), in asthma | Q34102503 |
| | Acute adrenal crisis in asthmatics treated with high-dose fluticasone propionate | Q34137816 |
| | Long-term budesonide or nedocromil treatment, once discontinued, does not alter the course of mild to moderate asthma in children and adolescents | Q34140471 |
| | The influence of lung deposition on clinical response. | Q34292645 |
| | Inhaled mometasone furoate: a review of its use in adults and adolescents with persistent asthma | Q34340426 |
| | Do inhaled corticosteroids inhibit growth in children? | Q34345371 |
| | Review of the molecular and cellular mechanisms of action of glucocorticoids for use in asthma | Q34610973 |
| | Molecular mechanisms of corticosteroid actions in chronic inflammatory airway diseases. | Q35054431 |
| | A randomised controlled trial of short term growth and collagen turnover in asthmatics treated with inhaled formoterol and budesonide | Q35267839 |
| | Daily or intermittent budesonide in preschool children with recurrent wheezing | Q35638542 |
| | Hydrofluoroalkane formulations of inhaled corticosteroids for the treatment of asthma | Q35790743 |
| | Oral and inhaled corticosteroids and adrenal insufficiency: a case-control study | Q36203058 |
| | Effects of inhaled corticosteroids on pathology in asthma and chronic obstructive pulmonary disease. | Q36236852 |
| | Effect of inhaled glucocorticoids in childhood on adult height | Q36454737 |
| | Clinical safety of inhaled corticosteroids for asthma in children: an update of long-term trials | Q36523269 |
| | Relevance of pharmacokinetics and pharmacodynamics of inhaled corticosteroids to asthma | Q36639392 |
| | Effects of inhaled steroids on growth, bone metabolism, and adrenal function | Q36647141 |
| | Use of beclomethasone dipropionate as rescue treatment for children with mild persistent asthma (TREXA): a randomised, double-blind, placebo-controlled trial | Q36854857 |
| | Daily versus as-needed inhaled corticosteroid for mild persistent asthma (The Helsinki early intervention childhood asthma study). | Q36869140 |
| | Ciclesonide--a novel corticosteroid for the management of asthma | Q37979257 |
| | Local and systemic safety of intranasal corticosteroids. | Q37997019 |
| | Are inhaled corticosteroids associated with an increased risk of fracture in children? | Q38479923 |
| | Effects of inhaled fluticasone on angiogenesis and vascular endothelial growth factor in asthma | Q40602423 |
| | A comparison of the efficacy and safety of inhaled corticosteroids in asthma | Q41559651 |
| | Pharmacokinetics and pharmacodynamics of inhaled corticosteroids | Q41752111 |
| | Candidiasis and dysphonia complicating beclomethasone treatment of asthma | Q42271357 |
| | Two-dimensional and three-dimensional imaging show ciclesonide has high lung deposition and peripheral distribution: a nonrandomized study in healthy volunteers. | Q51174299 |
| | Pharmacokinetics of flunisolide administered via metered dose inhaler with and without a spacer device and following oral administration. | Q52078152 |
| | Long-term effects of budesonide or nedocromil in children with asthma. | Q53809666 |
| | Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: The Pediatric Asthma Controller Trial | Q60639943 |
| | Morphological studies of bronchial mucosal biopsies from asthmatics before and after ten years of treatment with inhaled steroids | Q68029754 |
| | Pharmacokinetics of triamcinolone acetonide after intravenous, oral, and inhaled administration | Q71869746 |
| | Pharmacokinetics and metabolism of budesonide, a selective glucocorticoid | Q72054490 |
| | The pharmacokinetics of inhaled hydrofluoroalkane formulations | Q73251680 |
| | Drug delivery from the Turbuhaler and Nebuhaler pressurized metered dose inhaler to various age groups of children with asthma | Q73329526 |
| | Adrenal suppression, evaluated by a low dose adrenocorticotropin test, and growth in asthmatic children treated with inhaled steroids | Q73483999 |
| | One year treatment with salmeterol compared with beclomethasone in children with asthma. The Dutch Paediatric Asthma Study Group | Q73730724 |
| | Pharmacokinetic and pharmacodynamic properties of inhaled corticosteroids in relation to efficacy and safety | Q74217100 |
| | Growth in asthmatic children treated with fluticasone propionate. Fluticasone Propionate Asthma Study Group | Q74449900 |
| | The Diskus: a new multi-dose powder device--efficacy and comparison with Turbuhaler | Q77051164 |
| | Efficacy and safety of high-dose inhaled steroids in children with asthma: a comparison of fluticasone propionate with budesonide | Q77222405 |
| | Adverse effects of inhaled budesonide (800 micrograms) on growth and collagen turnover in children with asthma: a double-blind comparison of once-daily versus twice-daily administration | Q77577089 |
| | Improved airway targeting with the CFC-free HFA-beclomethasone metered-dose inhaler compared with CFC-beclomethasone | Q77759077 |
| | Comparison of the efficacy and safety of ciclesonide 160 microg once daily vs. budesonide 400 microg once daily in children with asthma | Q80583091 |
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P304 | page(s) | 66-73 | |
| P577 | publication date | 2014-12-31 | |
| P1433 | published in | The open respiratory medicine journal | Q27722050 |
| P1476 | title | The effects of inhaled corticosteroids on growth in children | |
| P478 | volume | 8 | |